FdaApplication
ANDA 217770
Identifiers
- fda_app_no: ANDA217770
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2024-08-14 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC |
1 product